Pharma & Biotech

Pharmaceutical giant Pfizer has announced significant progress across two distinct areas of its clinical pipeline, marking a pivotal moment in...

Mirum Pharmaceuticals is entering what could be its most transformative period. The rare disease specialist faces a packed calendar of...

Bayer AG finds itself at a confluence of strategic developments, with a new flagship location, steady share price action, and...

The stock of Redcare Pharmacy remains trapped in a pronounced and persistent downtrend, showing few signs of finding a stable...

The healthcare conglomerate Fresenius has reported a robust finish to its 2025 fiscal year, marked by significant profit growth. Despite...

The biotechnology firm Anavex Life Sciences is confronting significant operational and legal challenges following a major regulatory disappointment in Europe....

The U.S. Food and Drug Administration (FDA) has taken decisive action against ImmunityBio, issuing a formal warning letter over what...

While Eli Lilly continues to post impressive prescription figures for its blockbuster weight-loss medications, a growing sense of unease is...

The launch of the highly anticipated Wegovy pill on the Hims & Hers platform has been met with a tepid...

While its financial runway extends into 2028, Precision Biosciences (NASDAQ: DTIL) faces a period of clinical anticipation that is testing...